Chaplynska N. Clinical and pathogenetic evaluation of different forms of angina pectoris course: the properties of treatment

Українська версія

Thesis for the degree of Candidate of Sciences (CSc)

State registration number

0407U003913

Thesis Registration Form

0407U003913.pdf

Applicant for

Specialization

  • 14.01.11 - Кардіологія

12-10-2007

Specialized Academic Board

Д 20.601.01

Ivano-Frankivsk national medical university

Essay

Object - 154 patients.The 40 mg/day Simvastatin's usage from the first day of progressive anginas treatment promotes the reduction of the inflammation, the rise of the basic fibroblast growth factor and the stabilisation of the atherosclerotic plaques. The Quercetin's addition potentiates the hypolipidemic, antiinflammatory, antioxidant, antiaggregant, endotelium-protective effects, provides the decrease of the frequency of repeated hospitalization regarding ischemic heart disease destabilisation. Branch - medicine.

Read more

Files

Dis 1.doc

Dis 1.doc

Dis 2.doc

автореферат.doc

Similar theses

0524U000129

Oksana L. Rekovets

Сlinical and pathogenetic justification of individual diagnostic approaches and treatment programs in resistant arterial hypertension

0523U100016

Maslovskyi Valentyn Iuriyovych

Prognostic value of various clinical and instrumental markers and options for basic therapy to assess the quality of life and the nature of the course of myocardial infarction without elevation of the ST segment

0421U103208

Kovbasniuk Yuriy Vasylovych

Structure and functional myocardial changes and features of plasma hemostasis by patient with atrial fibrillation and different body mass index

0821U101742

Tanska Olha Oleksandrivna

Criteria for Patients to be Put on the Waiting List for Heart Transplantation

0821U101115

Kutia Inna Mykolaivna

Pathogenetic and prognostic value of vascular endothelial growth factor-A in acute myocardial infarction with the ST segment elevation